The aim of surveys on clinical practice is to stimulate discussion and optimize practice. In this paper the current Italian radiotherapy practice after breast-conserving surgery for early breast cancer is described and adherence to national and international guidelines is assessed. Furthermore, results are compared with an earlier survey in northern Italy and international reports.
Study Design
A multiple-choice questionnaire sent to all 138 Italian radiation oncology centers.
Results
48% of centers responded. Most performed breast-conserving surgery when tumor size was ≤3 cm. All centers routinely performed axillary dissection; 45 carried out sentinel node biopsy followed by axillary dissection when the sentinel node was positive. Most centers re-excised when resection margins were positive. The median interval between surgery and radiotherapy, when chemotherapy was not administered, was 60 days. Adjuvant chemotherapy was preferably administered before radiotherapy. Regional lymph nodes were never irradiated in 10 centers; in all others irradiation depended on the number of positive lymph nodes and/or involvement of axillary fat and/or tumor location in medial quadrants. All centers used standard fractionation; hypofractionated schemes were available in 6. Most centers used 4–6 MV photons. In 59 centers the boost dose of 10 Gy could be increased if margins were not negative. All centers ensured patient setup reproducibility. Treatment planning was computerized in 59 centers. The irradiation dose was prescribed at the ICRU point in 56 centers and portal films were made in 54 centers. Intraoperative radiotherapy was used in 4 centers: for partial breast irradiation in 1 and for boost administration in 3 centers.
Conclusions
Although the quality of radiotherapy delivery has improved in Italy in recent years, approaches that do not conform to international standards persist.
ValdagniR., AmichettiM., CioccaM.: Patterns of radiotherapy for early breast cancer in Northern Italy compared with European and national standards.Radiother Oncol, 51: 79–85, 1999.
2.
BartelinkH., GaravagliaG., JohanssonK.A., MijnheerB.J., van den BogaertW., van TienhovenG., YarnoldJ.: Quality assurance in conservative treatment of early breast cancer.Radiother Oncol, 22: 323–326, 1991.
3.
ValdagniR.: Standard di riferimento nell'irradiazione del cancro della mammella in stadio iniziale.Documento AIRO – AIFB, 1997.
4.
CeilleyE., JagsiR., GoldbergS., GrignonL., KachnicL., PowellS., TaghianA.: Radiotherapy for invasive breast cancer in North America and Europe: results of a survey.Int J Radiat Oncol Biol Phys, 61: 365–373, 2005.
5.
Kurtz J for the EUSOMA Working Party:The curative role of radiotherapy in the treatment of operable breast cancer.Eur J Cancer, 38: 1961–1974, 2002.
6.
KutcherG.J., CoiaL., GillinM., HansonW.F., LeibelF., MortonR.J., PaltaJ.R., PurdyJ.A., ReinsteinL.E., SvenssonG.K., WellerM., WingfieldL.: Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40.Med Phys, 21: 581–618, 1994.
7.
MorrowM., StromE.A., BassettL.W., DershawD.D., FowbleB., GiulianoA., HarrisJ.R., O'MalleyF., SchnittS.J., SingletaryE., WinchesterD.P.: Standard for breast conservation therapy in the management of invasive breast carcinoma.CA Cancer J Clin, 52: 277–300, 2002.
8.
PierceL.J., MoughanJ., WhiteJ., WinchesterD.P., OwenJ., WilsonJ.F.: 1998–1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.Int J Radiat Oncol Biol Phys, 62: 183–192, 2005.
9.
WhiteJ., MorrowM., MoughanJ., OwenJ., PajakJ., DesHarnaisS., WinchesterD.P., WilsonJ.F.: Compliance with breast-conservation standards for patients with early-stage breast carcinoma.Cancer, 97: 893–904, 2003.
LymanG.H., GiulianoA.E., SomerfieldM.R., BensonABIII, BodurkaD.C., BursteinH.J., CochranA.J., CodyHSIII, EdgeS.B., GalperS., HaymanJ.A., KimT.Y., PerkinsC.L., PodoloffD.A., SivasubramaniamV.H., TurnerR.R., WahlR., WeaverD.L., WolffA.C., WinerE.P.: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.J Clin Oncol, 23: 7703–7720, 2005.
12.
BentelG., MarksL.B., HardenberghP., ProsnitzL.: Variability of the location of internal mammary vessels and glandular breast tissue in breast cancer patients undergoing routine CT-based treatment planning.Int J Radiat Oncol Biol Phys, 44: 1017–1025, 1999.
13.
HurkmansC.W., BorgerJ.H., PietersB.R., RussellN.S., JansenE.P.M., MijnheerB.J.: Variability in target volume delineation on CT scans of the breast.Int J Radiat Oncol Biol Phys, 50: 1366–1372, 2000.
14.
BornsteinB.A., ChengC.W., RodhesL.M., RashidH., StomperP.C., SiddonR.L., HarrisJ.R.: Can simulation measurements be used to predict the irradiated lung volume in the tangential fields in patients treated for breast cancer?Int J Radiat Oncol Biol Phys,18: 181–187, 1990.
15.
ICRU 50:International Commission on Radiation Units and Measurements, Prescribing, Recording and Reporting Photon Beam Therapy, ICRU Report 50.International Commission on Radiation Units and Measurements, Bethesda, Maryland, 1993.
16.
CoxJ.D., StetzJ., PajakT.F.: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).Int J Radiat Oncol Biol Phys, 31: 1341–1346, 1995.
Radioterapia in Italia:censimento delle strutture e delle attività.Documento AIRO, 2002.
19.
VeronesiU., SaccozziR., Del VecchioM., BanfiA., ClementeC., De LenaM., GallusG., GrecoM., LuiniA., MarubiniE., MuscolinoG., RilkeF., SalvatoriB., ZecchiniA., ZucaliR.: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancer of the breast.N Engl J Med, 305: 6–11, 1981.
20.
VeronesiU., VolterraniF., LuiniA., SaccozziR., Del VecchioM., ZucaliR., GalimbertiV., RasponiA., Di ReE., SquicciariniP., SalvatoriB.: Quadrantectomy versus lumpectomy for small size breast cancer.Eur J Cancer, 26: 671–673, 1990.
21.
MorrowM., WhiteJ., MoughanJ., OwenJ., PajackT., SylvesterJ.A., WilsonJ.F., WinchesterD.: Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma.J Clin Oncol, 19: 2254–2262, 2001.
22.
GiulianoA.E., HaighP.I., BrennanM.B., HansenN.M., KelleyM.C., YeW., GlassE.C., TurnerR.R.: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.J Clin Oncol, 18: 2553–2559, 2000.
23.
VeronesiU., PaganelliG., VialeG., LuiniA., ZurridaS., GalimbertiV., IntraM., VeronesiP., RobertsonC., MaissonneuveP., RenneG., De CiccoC., De LuciaF., GennaiR.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.N Engl J Med, 349: 546–553, 2003.
24.
EdgeS.B., NilandJ.C., BookmanM.A., TheriaultR.L., OttesenR., LepistoE., WeeksJ.C.: Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers.J Natl Cancer Inst, 95: 1514–1521, 2003.
25.
SchwartzG.F., VeronesiU., CloughK.B., DixonJ.M., FentimanI.A., Heywang-KöbrunnerS.H., HollandR., HughesK.S., MargoleseR., OlivottoI.A., PalazzoJ.P., SolinL.J. and the Consensus Conference Committee: Proceedings of the Consensus Conference on Breast Conservation, Milan, Italy, April 28-May 1, 2005.Int J Radiat Oncol Biol Phys, 65: 1281–1288, 2006.
26.
HughesK.S., SchnaperL.A., BerryD., CirrincioneC., McCormickB., ShankB., WheelerJ., ChampionL.A., SmithT.J., SmithB.L., ShapiroC., MussH.B., WinerE., HudisC., WoodW., SugarbakerD., HendersonG., NortonL.: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.N Engl J Med, 351: 971–977, 2004.
27.
SmithI.E., RossG.M.: Breast radiotherapy after lumpectomy. No longer always necessary.N Engl J Med, 351: 1021–1023, 2004.
28.
MyersR.E., JohnstonM., PritchardK., LevineM., OliverT., and The Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative: Baseline staging tests in primary breast cancer: a practice guideline.CMAJ, 164: 1439–1444, 2001.
Rutgers EJ for the EUSOMA Consensus Group:EUSOMA Guidelines. Quality control in the locoregional treatment of breast cancer.Eur J Cancer, 37: 447–453, 2001.
31.
CuriglianoG., FerrettiG., ColleoniM., MarroccoE., PeruzzottiG., De CiccoC., PaganelliG., GoldhirschA.: Bone scan has no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms.Ann Oncol, 12: 724–725, 2001.
32.
LeeJ.E., ParkS.S., HanW., KimS.W., ShinH.J., OhS.K., YounY.K., NohD.Y., KimS.W.: The clinical use of staging bone scan in patients with breast carcinoma.Cancer, 104: 499–503, 2005.
33.
PuglisiF., FolladorA., MinisiniA.M., CardellinoG.G., RussoS., AndreettaC., Di TerlizziS., PigaA.: Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications.Ann Oncol, 16: 263–266, 2005.
34.
RavaioliA., PasiniG., PolselliA., PapiM., TassinariD., ArcangeliV., MilandriC., AmadoriD., BraviM., RossiD., FattoriP., PasquiniE., PanziniI.: Staging of breast cancer: new recommended standard procedure.Breast Cancer Res Treat, 72: 53–60, 2002.
35.
BentzenS.M., HeerenG., CottierB., SlotmanB., GlimeliusB., LievensY., van den Bogaert: Toward evidence-based guidelines for radiotherapy infrastructure and staffing in Europe: the ESTRO QUARTS project.Radiother Oncol, 75: 355–365, 2005.
36.
FisherB., BrownA.M., DimitrovN.V., PoissonR., RedmondC., MargoleseR.G., BowmanD., WolmarkN., WickerhamD.L., KardinalC.G.: Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: Results from the National Surgical Adjuvant Breast and Bowel Project B-15.J Clin Oncol, 8: 1483–1496, 1990.
37.
RechtA., ComeS.E., HendersonI.C., GelmanR.S., SilverB., HayesD.F., ShulmanL.N., HarrisJ.R.: The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer.N Engl J Med, 334: 1356–1361, 1996.
38.
WallgrenA., BernierJ., GelberR.D., GoldhirschA., RoncadinM., JosephD., Castiglione-GertschM.: Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer.Int J Radiat Oncol Biol Phys, 35: 649–659, 1996.
39.
ArcangeliG., PinnaròP., RamboneR., GiannarelliD., BenassiM.: A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer.Int J Radiat Oncol Biol Phys, 64: 161–167, 2006.
40.
BuzdarA.U., KauS.W., SmithT.L., AmesF., SingletaryE., StromE., McNeeseM., HortobagyiG.N.: The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer.Cancer, 71: 3680–3684, 1993.
41.
HuangJ., BarberaL., BrouwersM., BrowmanG., MackillopW.J.: Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review.J Clin Oncol, 21: 555–563, 2003.
42.
LeonardC.E., WoodM.E., ZhenB., RankinJ., WaitzD.A., NortonL., HowellK., SedlacekS.: Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?J Clin Oncol,13: 2906–2915, 1995.
43.
BorgerJ., KempermanH., HartA., PeterseH., van DongenJ., BartelinkH.: Risk factors in breast-conservation therapy.J Clin Oncol, 12: 653–660, 1994.
44.
DewarJ.A., ArriagadaR., BenhamouS., BenhamouE., BretelJ.J., Pellae-CossetB., MarinJ.L., PetitJ.Y., ContessoG., SarrazinD.for the IGR Breast Cancer Group: Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970–1982).Cancer, 76: 2260–2265, 1995.
45.
FreedmanG., FowbleB., HanlonA., NicolaouN., FeinD., HoffmanJ., SigurdsonE., BoraasM., GoldsteinL.: Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.Int J Radiat Oncol Biol Phys, 44: 1005–1015, 1999.
46.
GageI., SchnittS.J., NixonA.J., SilverB., RechtA., TroyanS.L., EberleinT., LoveS.M., GelmanR., HarrisJ.R., ConnollyJ.L.: Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.Cancer, 78: 1921–1928, 1996.
47.
SmittM.C., NowelsK.W., ZdeblickM.J., JeffreyS., CarlsonR.W., StockdaleF.E., GoffinetD.R.: The importance of lumpectomy surgical margin status in long term results of breast conservation.Cancer, 76: 259–267, 1995.
48.
WazerD.E., Schmidt-UllrichR.K., RuthazerR., SchmidC.H., GrahamR., SafaiiH., RothschildJ., McGrathJ., ErbanJ.K.: Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.Int J Radiat Oncol Biol Phys, 40: 851–858, 1998.
49.
CutuliB., CottuP.H., GuastallaJ.P., MechinH., CostaA., JourdanR.: A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients.Breast Cancer Res Treat, 95: 55–64, 2006.
50.
OlivottoI.A., ChuaB., ElliottE.A., PardaD.S., PierceL.J., ShepherdL., VallowL.A., WhiteJ.R., WhelanT.J.: A clinical trial of breast radiation therapy in early-stage breast cancer: The MA20 trial.Clin Breast Cancer, 4: 361–363, 2003.
51.
FortinA., DagnaultA., LarochelleM., VuT.T.: Impact of locoregional radiotherapy in node-positive patients treated by breast-conservative treatment.Int J Radiat Oncol Biol Phys, 56: 1013–1022, 2003.
52.
HellmanS.: Stopping metastases at their source.N Engl J Med, 337: 996–997, 1997.
53.
WhelanT., MacKenzieR., JulianJ., LevineM., ShelleyW., GrimardL., LadaB., LukkaH., PereraF., FylesA., LaukkanenE., GulavitaS., BenkV., SzechtmanB.: Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.J Natl Cancer Inst, 94: 1143–1150, 2002.
54.
MijnheerB.J., HeukelomS., LansonJ.H., van BattumL.J., van BreeN.A.M., van TienhovenG.: Should inhomogeneity corrections be applied during treatment planning of tangential breast irradiation?Radiother Oncol,22: 239–244, 1991.
55.
PierceL.J., GriffithK.A., HaymanJ.A., DouglasK.R., LichterA.S.: Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results.Int J Radiat Oncol Biol Phys, 61: 1317–1327, 2005.
56.
DasI.J., ChengC.W., FeinD.A., FowbleB.: Patterns of dose variability in radiation prescription of breast cancer.Radiother Oncol, 44: 83–89, 1997.
57.
KutcherG.J., SmithA.R., FowbleB.L., OwenJ.B., HanlonA., WallaceM., HanksG.E.: Treatment planning for primary breast cancer: a patterns of care study.Int J Radiat Oncol Biol Phys, 36: 731–737, 1996.
58.
PalazziM., TomatisS., ValliM.C., GuzzetiR., TonoliS., BertoniF., MagriniS.M., MeregalliS., AsnaghiD., ArientiV., PradellaR., CafaroI.: Impact of radiotherapy technique on the outcome of early breast cancer treated with conservative surgery: A multicenter observational study on 1,176 patients.Int J Radiat Oncol Biol Phys, 65: 1361–1367, 2006.
59.
RomestaingP., LehingueY., CarrieC., CoquardR., MontbarbonX., ArdietJ.M., MamelleN., GérardJ.P.: Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.J Clin Oncol, 15: 963–968, 1997.
60.
BartelinkH., HoriotJ.C., PoortmansP., StruikmansH., Van den BogaertW., BarillotI., FourquetA., BorgerJ., JagerJ., HoogenraadW., ColletteL., PierartM.: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.N Engl J Med, 345: 1378–1387, 2001.
61.
RabinovitchR., FinlaysonC., PanZ., LewinJ., HumphriesS., BifflW., FrancioseR.: Radiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: a prospective clinical study.Int J Radiat Oncol Biol Phys, 47: 313–317, 2000.
62.
WeedD.W., YanD., MartinezA.A., ViciniF.A., WilkinsonT.J., WongJ.: The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation.Int J Radiat Oncol Biol Phys, 60: 484–492, 2004.
